EU unimpressed by May’s Brexit plans – but Witty commends ‘edge’
May sets out plans to leave single market, and aim for EU free trade deal
A look ahead to the UK market in 2017 through the eyes of pharma industry leaders
Moving EMA could slow approval process, warns Guido Rasi
The implications for global pharma HQs and what the UK needs to do.
Exclusive survey finds concerns about future of UK pharma industry
The UK government wants a ‘bespoke’ deal for pharma – but the EU has other ideas.